Description
In Vitro Diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning. Kalorama’s 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning.
Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has country-level markets and forecasts.
If you need geographical IVD markets by country from an authoritative source, this report also provides that. Up to date as of Q1 2023, this report is designed to cover every significant world IVD market.
- One Report Covering 30 Countries
- Reliable Estimates From an IVD-Focused Analyst Team (The Authors of Kalorama’s Worldwide Market for In Vitro Diagnostics)
- Sizing for 19 Important IVD Market Segments
- Segments Estimated for Each Country
- Lab-Based and POC Segments for Many Disease Areas
- Designed to Align with Other Kalorama Reports
- Forecasts in Revenue to 2027 for Each Segment
- CAGRS for Each Segment and Country
- Updated Quarterly (4 updates annually) to Reflect Market Changes
- Analyst Notes for Significant Developments
- Definitions and Descriptions of Tests
- Over 2800 Data Points
Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic coverage. As a result, we are offering geographic research and analysis focused at the country, rather than regional level in our 30 Country In Vitro Diagnostics (IVD) Market Atlas. A quarterly-updated, 30-country market research report with the major IVD segments forecasted out five years.
To replicate the 2800+ data points in the IVD Market Atlas, you’d need to buy dozens of other companies market research studies.
This quarterly updated report contains IVD markets aligned to Kalorama’s expert global estimates in our Worldwide Market for In Vitro Diagnostics, segmented for 30 important country markets and for 19 key test segments.
Countries covered in the IVD Market Atlas include:
- Australia
- Austria
- Belgium
- Brazil
- Canada
- Chile
- China
- Egypt
- France
- Germany
- India
- Indonesia
- Italy
- Japan
- Mexico
- Netherlands
- Poland
- Romania
- Russia
- Saudi Arabia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Vietnam
Market researchers will tend to sell reports for each of these countries, rather than combine in one report. For Kalorama, our mission is different. We seek to keep companies informed with useful references when they need it, rather than publish hundreds of reports a year. The IVD Market Atlas reflects this mission.
It’s important to note that for each of these countries, there is an overall IVD market estimate and then, the most important market segments are broken out. These include:
- Blood Bank Immunoassays
- Blood Bank Molecular (NAT)
- Clinical Chemistry
- Coagulation
- COVID-19
- Critical Care
- FOB
- Glucose
- Hematology
- Histology/Cytology
- ID/AST Microbiology
- Immunoassays
- Immunoassays, Micro
- Molecular, Micro
- Molecular, Others
- Overall Country IVD
- Point of Care
- POC Infectious Disease
- Pregnancy Testing
While these are not every segment possible, they are the most important [most searched for/requested and largest] IVD market segments.
The report is updated every 3 months. Why? This is to keep up with market changes. It was once the case that the IVD market didn’t change rapidly. COVID-19, international changes, M&A activity, new products, point of care trends and regulatory activity have all worked together to change that. While there may not be substantial change in markets between one quarter and another, the report will catch segment changes, and you will always have an updated data set for your business planning.
Those who subscribe will be placed on our Knowledge Center product and will receive quarterly updates.
FULL REPORT CONTENTS
U.S. IVD Market
U.S. IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Germany IVD Market
Germany IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Japan IVD Market
Japan IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
China IVD Market
China IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
France IVD Market
France IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
United Kingdom IVD Market
United Kingdom IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Italy IVD Market
Italy IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Canada IVD Market
Canada IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Spain IVD Market
Spain IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Australia IVD Market
Australia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Brazil IVD Market
Brazil IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Russia IVD Market
Russia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
India IVD Market
India IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Switzerland IVD Market
Switzerland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Netherlands IVD Market
Netherlands IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Poland IVD Market
Poland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Turkey IVD Market
Turkey IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Sweden IVD Market
Sweden IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Belgium IVD Market
Belgium IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Mexico IVD Market
Mexico IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Austria IVD Market
Austria IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Saudi Arabia IVD Market
Saudi Arabia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
South Korea IVD Market
South Korea IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Romania IVD Market
Romania IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Egypt IVD Market
Table 26-1: Egypt IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Indonesia IVD Market
Indonesia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chile IVD Market
Chile IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
South Africa IVD Market
South Africa IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
United Arab Emirates IVD
United Arab Emirates IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Vietnam IVD Market
Vietnam IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
